Image guided therapy or image guided interventions help surgeons by navigating the devices inside the body of patients and provides a three dimensional image of the targeted area, making the surgery safer and less invasive. The constant flow of information enables surgeons to plan for surgery, make minute adjustments to treat across various therapeutic areas, including cardiac, vascular, endovascular, pain, trauma, urology, orthopedics, spine, and neurology. Image guided therapy devices also can be potentially used in the treatment of hypertension through renal denervation. All these therapeutic areas rely on powerful imaging modalities, including computed tomography (CT), magnetic resonance imaging (MRI), fixed interventional X-ray, and mobile C-arms. Each modality has advantages and limitations and differs according to its mode of operation, level of complexity, and price point. As the fields of minimally-invasive interventions, interventional imaging, and image-guided surgery (IGS) continue to mature, the advancements in integration of image guided therapy system market with therapeutic modalities in real time is expected to lead to major growth over the forecast period.
Adoption of these systems by various hospitals is expected to propel the growth of the Image guided therapy systems market
Image guided therapy systems provides doctors and technicians with access to patient database records and accordingly develop exact detailed surgical plan or the optimal path to the targeted area. In addition, ultrasound recording during surgery makes the image guided therapy safer and helps the surgeon to operate on the targeted area avoiding any critical injury to the nearby parts of the area. Various hospitals are focusing on installing image guided system to offer wide range of interventional procedures to patients. For instance, in November, 2017, UnityPoint Health, a network of hospitals, clinics and home care services in Iowa, Illinois, U.S. and Wisconsin installed Infinix-i-4-D CT (computed tomography) system, a product by Toshiba Medical which offers fast, safe and accurate interventional radiology (IR) and oncology procedures, such as tumor therapy, embolization, arterial interventions, dialysis and stent placement. These rising demand among the hospitals expected to fuel the growth of the image guided therapy system market. Moreover image guided therapy systems have significantly improved, resulting in more precise and safer intervention. An example of such advancement is, in November 2017, Siemens Healthineers has launched Nexaris therapy system to integrate multimodal imaging in interventional radiology and surgery. However in May 2019, Getinge a global provider of innovative solutions for operating rooms has launched the PILOT in conjunction with Siemens Healthineers’ Nexaris system. PILOT is a patient-centered transfer system which allows surgical staff to move patients between imaging systems and treatment rooms without repositioning of therapy systems.
Regionally, image guided therapy system market is segmented into North America, Europe, Latin America, Asia Pacific, Middle East and Africa. North America is estimated to account for the largest market share in 2017, owing to continuous funding by government to facilitate integration of image guided therapy technology among research centers. For instance, in 2018, Cancer Imaging Program (CIP) has announced the Funding Opportunity Announcement (FOA) to the imaging based clinical involved in clinical trial processes in the U.S. This programme is to support the co-clinical trials research and development of integrated imaging-based systems for delivery of drugs or biologics in cancer and other diseases.
Various strategies adopting by market players will have a lucrative market growth on image guided therapy system market
Development of these devices has created further demand for manufacturers in this image guided therapy system market to create tailored technologies and imaging modality that help improve patient’s outcomes, thus reducing the burden on healthcare system. Philips Healthcare is continuously capitalizing on image guided therapy as a core pillar of its growth strategy in imaging, operating high-profile partnerships, acquisitions, and product launches in this area. For instance, in January 2019, Philips Healthcare launched Azurion with flexArm, its next generation image-guided therapy platform, capable of performing a wide range of routine, as well as minimally-invasive, catheter-based procedures in the interventional lab or hybrid operating room (OR). Furthermore, on January, 2018, Varian Medical System signed an agreement to acquire Sirtex Medical Ltd., an Australia-based global life sciences company focused on interventional oncology therapies so that Varian leverage its capabilities in combination with Sirtex's interventional oncology platform in treatment planning and delivery, image guidance and processing, oncology practice management software, and radiation safety.
Key players in this image guided therapy system market includes General Electric Company, Toshiba Medical Systems, Siemens AG, Medtronic plc, Brain lab AG, Image Guided Therapy, and Ziehm Imaging, Koninklijke Philips N.V., Varian Medical System, Inc.
Image Guided Therapy System Market Taxonomy:
By End User: